List of Studies ( Metabolite:3-(N-Acetyl-L-cystein-S-yl) acetaminophen)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003917 | AN006432 | Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure | Feces | Human | Allergy | University of California, San Francisco | LC-MS |
| ST003867 | AN006355 | Fatty-acid oxidation is a metabolic hallmark of human proliferative retinopathy | Eye tissue | Human | Retinopathy | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006443 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Meningitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003788 | AN006443 | Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality | Cerebrospinal fluid | Human | Tuberculosis | Broad Institute of MIT and Harvard | LC-MS |
| ST003520 | AN005780 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | LC-MS |
| ST003032 | AN004971 | Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens | Urine | Human | National Center for Advancing Translational Sciences | Other | |
| ST002903 | AN004762 | Identification and targeting of microbial putrescine acetylation in bloodstream infections | Blood | Human | Septic shock | Broad Institute of MIT and Harvard | LC-MS |
| ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002818 | AN004588 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | Other | |
| ST002536 | AN004171 | Effectors enabling adaptation to mitochondrial complex I loss in Hürthle cell carcinoma | Thyroid | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | LC-MS |
| ST002471 | AN004033 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002470 | AN004029 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling | Blood | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002246 | AN003666 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001835 | AN002977 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Blood | Human | Idaho Veterans Research and Education Foundation | LC-MS | |
| ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001521 | AN002533 | Plasma metabolites of known identity profiled using hybrid nontargeted methods (part-III) | Blood | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001517 | AN002519 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001516 | AN002516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001515 | AN002513 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Blood | Human | Obesity | Translational Research Institute- AdventHealth Orlando | LC-MS |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | LC-MS | |
| ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | LC-MS | |
| ST001402 | AN002344 | Ontogeny related changes in the pediatric liver metabolome | Liver | Human | Moffitt Cancer Center | LC-MS | |
| ST001400 | AN002341 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001237 | AN002055 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part III | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST001236 | AN002054 | Metabolic responses to PD1 immune-checkpoint blockade and association with therapeutic benefits - Part II | Blood | Human | Cancer | Broad Institute of MIT and Harvard | LC-MS |
| ST000976 | AN001597 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | LC-MS |
